secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2026-06-05T20:19:29+00:00
Accession:  0001213900-26-065828
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive raises ATM capacity to $150M; files new $50M shelf registration
-------------------------------------------------------------------------

- Entered Amendment No. 2 to Sales Agreement with Guggenheim Securities on June 5, 2026.
- ATM offering capacity increased from $100M to $150M in aggregate offering price.
- Also filed a new S-3 registration statement to sell an additional $50M of common stock.
- Previous agreements: initial Sales Agreement Nov 13, 2024; Amendment No. 1 Nov 14, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390026065828/0001213900-26-065828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390026065828/ea0291976-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-065828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer